David DiLillo

Company: Regeneron Pharmaceuticals

Job title: Senior Director, Immuno-Oncology

Seminars:

Progressing Co-Stimulatory Bispecific Antibodies for Streamlined Translation into the Clinic & Beyond 8:30 am

Delving into Regeneron’s advancing co-stimulatory bispecific pipeline Combinations of co-stimulatory bispecifics to better mimic natural T cell responses Next-gen costimulatory molecules and case studiesRead more

day: Day Two